-
Stocks mixed with tech firms back under pressure
-
New Australia coach Kiss gives Japan starts to Ross, Amatosero
-
How Blundell's old school tactic ended England's 'Bazball' era
-
'Stretch our money': Romanians face highest EU inflation
-
Israel reports troop deaths as Lebanon talks underway in Rome
-
Iran says close to Hormuz plan with Oman, but reopening depends on US
-
Seeds Rybakina, Pegula, Gauff reach third round at WTA Toronto
-
Messi scores twice to set Leagues Cup record in Miami victory
-
Police raid South Korea FA in probe into World Cup coach appointment
-
Asian stocks mostly down with tech firms back under pressure
-
Low water on Germany's Rhine river threatens new blow to economy
-
Back to the future as world champion Springboks host All Blacks
-
Ex-Wallabies Foley, Phipps rejoin Waratahs ahead of home World Cup
-
India youth protests highlight mistrust in 'lapdog' media
-
Rising Kenyan lakes push crocodiles closer to homes
-
Pacific islands alarmed by Trump-backed push for deep-sea mining
-
Istanbul cymbals: From Ottoman war tool to pulse of global music
-
Erratic rains dictate menu at three-star Michelin restaurant in Brazil
-
Myanmar ex-junta chief on first Thailand trip as civilian leader
-
Zverev, Auger-Aliassime and Medvedev exit Montreal Masters
-
Environmental disaster looms as tanker leaks off Oman
-
Google-parent Alphabet shakes up AI division
-
Embattled Infantino sees minnows Malawi reach WAFCON quarter-finals
-
FIFA back Infantino, apologise for World Cup privatisation plan
-
Seeds Rybakina, Pegula and Gauff advance at WTA Toronto event
-
Auger-Aliassime out of Montreal ATP event with injury
-
Zverev, Auger-Aliassime exit star-short Montreal Masters
-
Colombian baby hippo of Escobar stock dies after rescue
-
Embattled FIFA chief Infantino in emergency talks in Morocco
-
Preakness shifts 2027 dates to entice more Derby horses
-
Castaway SpaceX rocket stage crashed into Moon, scientists say
-
Guatemalan volcano eruption ends, locals return home
-
Dow edges to record as markets parse prospects for Hormuz deal
-
WHO chief urges stronger Ebola response in DR Congo visit
-
Salah arrives in Turkey to complete Trabzonspor move
-
Newcastle appoint Jaissle as new head coach after Howe exit
-
AFP journalist to be honored at International Press Freedom Awards
-
Swiss ski star Lara Gut-Behrami calls time on 18-year career
-
Turkish MPs back limited amnesty for Kurdish militants
-
US indicts leaders of Mexico's CJNG cartel, ups reward money
-
Noosha Aubel: Czy poradzi sobie z problemami Poczdamu?
-
Noosha Aubel: Είναι σε θέση να αντιμετωπίσει τα προβλήματα του Πότσδαμ;
-
Noosha Aubel: Klarar hon av Potsdams problem?
-
نوشا أوبيل: هل هي على مستوى التحديات التي تواجهها بوتسدام؟
-
Noosha Aubel: Zvládne problémy Postupimi?
-
Former England fly-half Burns retires from rugby union
-
Brazil hits new diplomatic lows with US and Argentina
-
Pakistan beat West Indies by eight wickets to level series
-
NZ boxer Parker promises ring return after doping ban 'lifted'
-
Reusser holds lead as Vollering wins in Tour de France hills
Particle physics pushing cancer treatment boundaries
Researchers at Europe's science lab CERN, who regularly use particle physics to challenge our understanding of the universe, are also applying their craft to upend the limits to cancer treatment.
The physicists here are working with giant particle accelerators in search of ways to expand the reach of cancer radiation therapy, and take on hard-to-reach tumours that would otherwise have been fatal.
In one CERN lab, called CLEAR, facility coordinator Roberto Corsini stands next to a large, linear particle accelerator consisting of a 40-metre metal beam with tubes packed in aluminium foil at one end, and a vast array of measurement instruments and protruding colourful wires and cables.
The research here, he told AFP during a recent visit, is aimed at creating very high energy beams of electrons -- the negatively charged particles in the nucleus of an atom -- that eventually could help to combat cancerous cells more effectively.
They are researching a "technology to accelerate electrons to the energies that are needed to treat deep-seated tumours, which is above 100 million electron volts" (MeV), Corsini explained.
The idea is to use these very high energy electrons (VHEE) in combination with a new and promising treatment method called FLASH.
- Reducing 'collateral damage' -
This method entails delivering the radiation dose in a few hundred milliseconds, instead of minutes as is the current approach.
This has been shown to have the same destructive effect on the targeted tumour, but causes far less damage to the surrounding healthy tissue.
With traditional radiation therapy, "you do create some collateral damage," said Benjamin Fisch, a CERN knowledge transfer officer.
The effect of the brief but intense FLASH treatment, he told reporters, is to "reduce the toxicity to healthy tissue while still properly damaging cancer cells."
FLASH was first used on patients in 2018, based on currently available medical linear accelerators, linacs, that provide low-energy electron beams of around 6-10 MeV.
At such low energy though, the beams cannot penetrate deeply, meaning the highly-effective treatment has so far only been used on superficial tumours, found with skin cancer.
But the CERN physicists are now collaborating with the Lausanne University Hospital (CHUV) to build a machine for FLASH delivery that can accelerate electrons to 100 to 200 MeV, making it possible to use the method for much more hard-to-reach tumours.
- 'Game-changer' -
Deep-lying cancer tumours that can't be rooted out using surgery, chemotherapy or traditional radiation therapy are often today considered a death sentence.
"It is the ones which we don't cure at the moment which will be the targets," Professor Jean Bourhis, head of CHUV's radiology department, told AFP.
"For those particular cancers, which may be one third of the cancer cases, it could be a game-changer."
There are particular hopes that the FLASH method, with its far less harmful impact on surrounding tissue, could make it possible to go after tumours lodged in the brain or near other vital organs.
Bourhis said it might not relegate deaths from stubborn cancer tumours to the history books, "but at least there will be a new opportunity for more cures, if it works."
- 'Compact' -
One challenge is making the powerful accelerator compact enough to fit inside a hospital.
At CERN, a large gallery has been dedicated to housing the CLEAR accelerator, which requires 20 metres to push the electrons up to the required energy level -- and another 20 metres to condition, measure and deliver the beam.
But Corsini insisted that CERN had the know-how to "accelerate in a much more compact space".
The prototype being designed with CHUV will aim to do the same job with a machine that is 10 metres overall.
This "compact" solution, Corsini said, "reduces the cost, reduces power consumption and variability, and you can easily put it into a hospital without having to build a whole building."
Construction of the prototype is scheduled to begin next February, and patient clinical trials could begin in 2025, Bourhis said, "if everything goes smoothly".
A.S.Diogo--PC